Skip to main content
NewslettersWatchlist

Balchem Corp(BCPC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low180.09
Day High181.63
Open:181.22
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Balchem Corporation to Present at Baird’s 54th Annual Global Industrial Conference on November 13, 2024
GlobeNewswire
Balchem Corporation Reports Third Quarter 2024 Financial Results
GlobeNewswire
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024
Motley Fool
Balchem (BCPC) Q2 2022 Earnings Call Transcript
Globe Newswire
Balchem Corporation Reports Second Quarter Sales of $236.7 Million, Net Earnings of $29.8 Million, GAAP EPS of $0.92, and Adjusted EPS of $1.07
Globe Newswire
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 29, 2022
Globe Newswire
Balchem Corporation Completes Acquisition of Kappa Bioscience AS
Globe Newswire
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS
Motley Fool
Balchem (BCPC) Q1 2022 Earnings Call Transcript
Globe Newswire
Balchem Corporation Reports First Quarter Sales of $228.9 Million, Net Earnings of $28.9 Million, GAAP EPS of $0.89, and Adjusted EPS of $1.03
Globe Newswire
Balchem Releases 2021 Sustainability Report
Globe Newswire
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 29, 2022
Motley Fool
Balchem (BCPC) Q4 2021 Earnings Call Transcript
Globe Newswire
Balchem Corporation Reports Record Fourth Quarter Sales of $213.1 Million and Net Earnings of $24.9 Million, GAAP EPS of $0.76 and Adjusted EPS of $0.85
Business Wire
Ortelius Nominates Six Highly Qualified and Independent Candidates for Election to the Board of Directors of Trecora Resources
Globe Newswire
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 18, 2022
Globe Newswire
Balchem Corporation Named on Newsweek’s 2022 List of America’s Most Responsible Companies
Globe Newswire
Groundbreaking Study Reinforces Need for Increased Choline Supplementation During Pregnancy
Globe Newswire
Balchem Corporation to Present at the CJS Securities 22nd Annual New Ideas for the New Year Conference January 12, 2022
Globe Newswire
Balchem Corporation Announces Dividend
Globe Newswire
Balchem Corporation to Participate in the Virtual Stephens Annual Investment Conference on November 29, 2021
Globe Newswire
Balchem Corporation to Participate in the Baird 2021 Global Industrial Conference on November 10, 2021

Profile

Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.